24 Jan (NucNet): The Australian Nuclear Science and Technology Organisation (Ansto) has awarded an 83 million Australian dollars (73 million US dollars, 52 million euros) contract to construction company Watpac to design and build a facility to produce the medical radioisotope molybdenum-99 (Mo-99) from uranium targets irradiated in the Opal reactor.
…
Ansto Awards USD 73 Million Contract For Mo-99 Facility
Source: NucNet
Archived news summary. This item reflects its original publication date. Follow the source link below for the publisher’s full article.
Questions about this archived item? Contact Nuclear Street.